Amendment history : Corrigendum ( September 2018 ) JAK 2 / IDH-mutant – driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
暂无分享，去创建一个
J. Teruya-Feldstein | Kwok-Kin Wong | M. V. Heiden | K. Yen | R. Levine | C. Thompson | Efthymia Papalexi | F. Rapaport | A. Intlekofer | A. Shih | Allison N. Lau | Elizaveta Freinkman | Minal A. Patel | A. Chiu | R. Rampal | Jihae Ahn | A. McKenney | Esra A. Akbay | K. Shank | B. Spitzer | Amritha Varshini Hanasoge Somasundara | E. Akbay | R. Nagaraja | Mya Steadman | Franck Rapaport | M. Heiden | Kwok-kin Wong | C. Thompson | R. Levine